Boji Medical Sells Fluconazole Ear Drops Technology to Chengdu Pusch for $2M
Boji Medical Technology Co., Ltd. (SHE: 300404), a Chinese clinical research organization (CRO), has entered...
SHE: 300404
Boji Medical’s FCZR Approved for Otomycosis Trials – First Liquid Eardrop in China
Boji Medical Technology Co., Ltd. (SHE: 300404) has secured approval from the National Medical Products...
Boji Medical’s Huasheng Transfers Glucosamine Sulfate Capsules Technology to Panlong
On March 20, 2025, Boji Medical Technology Co., Ltd (known as Boji Biomedicals) (SHE: 300404)...
Boji Medical Technology Receives NMPA Approval for TBA Clinical Study in Drug-Resistant Tuberculosis
China-based Clinical Research Organization (CRO) Boji Medical Technology Co., Ltd. (SHE: 300404) has announced receiving...
Guangzhou Boji Medical and CapitalBio Pharma Form Joint Venture to Innovate in Traditional Chinese Medicine
Guangzhou Boji Medical Biotechnological Co., Ltd, a Clinical Research Organization (CRO) based in China and...